SHMT2 and neuroblastoma: As shown in Figure 1A, increased SHMT2 expression was associated with a significant decrease in OS in NB patients, with an OS of 39% in patients with high SHMT2 expression compared to an OS of 80% in patients with low SHMT2 expression.